MAPK3 and osteoporosis: Bergamot extracts, by reducing cytokine levels and modulating NF-κB signaling, may inhibit osteoclastic activity and promote bone formation through β-catenin activation and ERK1/2 phosphorylation, thus improving bone density and lowering the risk of osteoporosis [8,34].